Senator questions FDA, Synthes on possible conflicts of interest

02/27/2008 | NYTimes.com

The FDA and Synthes, maker of the Prodisc artificial spinal disc, received letters of inquiry from Sen. Charles E. Grassley, R-Iowa, regarding possible conflicts of interest among doctors connected to the clinical trials of the device. A Synthes spokesman said the company will cooperate in the inquiry, while an FDA spokeswoman said the agency does not comment on pending requests.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC